VOLPENGO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 333
EU - Europa 212
AS - Asia 83
AF - Africa 5
OC - Oceania 3
SA - Sud America 2
Totale 638
Nazione #
US - Stati Uniti d'America 331
IT - Italia 57
CN - Cina 56
AT - Austria 29
FR - Francia 26
SE - Svezia 25
IE - Irlanda 19
UA - Ucraina 17
DE - Germania 11
VN - Vietnam 10
FI - Finlandia 8
PL - Polonia 6
SN - Senegal 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
GB - Regno Unito 4
JP - Giappone 4
SG - Singapore 4
AU - Australia 3
IL - Israele 3
BR - Brasile 2
CA - Canada 2
IN - India 2
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
KR - Corea 1
NL - Olanda 1
TR - Turchia 1
Totale 638
Città #
Chandler 54
Beijing 38
Fremont 28
Vienna 27
Dublin 19
Torino 19
Ashburn 18
Dearborn 18
Nyköping 15
Villeurbanne 15
Ann Arbor 11
Wilmington 10
Fairfield 8
Houston 8
Jacksonville 8
Medford 8
Pisa 8
Princeton 6
Redwood City 6
Woodbridge 5
Düsseldorf 4
San Jose 4
Warsaw 4
Cambridge 3
Dong Ket 3
Duncan 3
Hefei 3
Shanghai 3
Venice 3
Boardman 2
Chengdu 2
Fuzhou 2
Gdynia 2
Los Angeles 2
Montigny-le-bretonneux 2
Nutley 2
Piossasco 2
Rome 2
Saint-Fons 2
San Mateo 2
Seattle 2
Singapore 2
Tel Aviv 2
Tianjin 2
Toronto 2
Wuhan 2
Adelaide 1
Amsterdam 1
Basel 1
Boston 1
Brescia 1
Bronx 1
Carol Stream 1
Central 1
Costa Mesa 1
Easton 1
Esslingen am Neckar 1
Göttingen 1
Haifa 1
Izmir 1
Jakarta 1
Jersey City 1
Jinan 1
Nanchang 1
Nanjing 1
New Haven 1
New York 1
Norwalk 1
Prague 1
Recife 1
Sydney 1
São Paulo 1
Turin 1
Venezia 1
Washington 1
Zurich 1
Totale 423
Nome #
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes 202
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 107
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS 103
ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN 102
EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS 84
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor 67
Totale 665
Categoria #
all - tutte 1.807
article - articoli 0
book - libri 0
conference - conferenze 1.128
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202070 4 6 3 8 5 17 7 0 7 6 4 3
2020/202183 4 7 3 2 16 2 8 2 4 1 15 19
2021/202271 5 2 1 4 2 0 6 0 3 3 32 13
2022/2023135 12 14 2 26 7 30 3 13 12 6 7 3
2023/202451 4 17 3 2 8 7 0 5 0 2 0 3
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 665